$47.46 Million Extracellular Matrix Market - Global Analysis and Forecasts to 2027 - ResearchAndMarkets.com

DUBLIN--()--The "Extracellular Matrix Market to 2027 - Global Analysis and Forecasts by Application; Raw Material and Geography" report has been added to ResearchAndMarkets.com's offering.

The global extracellular matrix market is expected to reach US$ 47.46 Mn in 2027 from US$ 24.30 Mn in 2018. The extracellular matrix market is estimated to grow with a CAGR of 8.2% from 2019-2027.

The market is driven by the factors such as, significantly increasing incidences of trauma and cardiovascular diseases, increasing vascular reconstruction procedures and increasing product launches are likely to drive the growth of the extracellular matrix market. However, challenges during the usage of decellularized extracellular matrix is major challenge for the growth of the extracellular matrix market.

The significantly rising incidences of the orthopedic trauma conditions and cardiovascular diseases among others are the leading factors for the market growth. As a part of the treatment extracellular matrix serve several advantages for treating different chronic injuries caused due to surgery, accidents, chronic diseases and others.

Chronic diseases such as cancer, heart diseases, musculoskeletal diseases, and others are the leading causes of death and disability. The awareness about the technologically advanced treatment and minimally invasive procedures demands treatments that are effective in less time. Thus, one of the advantage of the extracellular matrix serve the demand of the patients. However, technically advanced procedures requires higher care cost, for instance, according to the National Center for Chronic Disease Prevention and Health Promotion, chronic diseases takes up US$3.3 trillion in annual health care costs. Therefore, the higher expenditures are also expected to drive the growth of market and provide better services.

In addition, the surgical orthopedic treatment including joint arthroscopy, fracture repair, general repair procedures on damaged muscle or tendon and corrective surgery requires extracellular matrix. These conditions are generally caused due to the sports and road accidents. For instance, according to the National Safety Council, in 2015, in the US, population in the age group from 5 to 14 accounted to 51% of total football injuries treated in emergency rooms. Thus, owing to the above mentioned factors the market is likely to propel during the forecast period.

Global extracellular matrix market was segmented by application and raw material. On the basis of the application the market is segmented as vascular repair and reconstruction, dural repair, wound healing, cardiac repair, pericardial repair and soft tissue repair. Based on the raw material the extracellular matrix market is segmented into bovine, porcine and others. Among the application segment soft tissue repair market held the largest market share. And on the basis of the raw material porcine segment held the largest market share.

Key Topics Covered:

1. Introduction

1.1 Scope Of The Study

1.2 Report Guidance

1.3 Market Segmentation

2. Global Extracellular Matrix Market - Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Extracellular Matrix- Market Landscape

4.1 Overview

4.2 PEST Analysis

5. Global Extracellular Matrix Market - Key Industry Dynamics

5.1 Key Market Drivers

5.1.1 Significantly Increasing Incidences Of Trauma And Cardiovascular Diseases

5.1.2 Increasing Vascular Reconstruction Procedures

5.1.3 Increasing Product Launches

5.2 Key Market Challenge

5.2.1 Challenges During The Usage Of Decellularized Extracellular Matrix

5.3 Key Market Opportunities

5.3.1 Opportunities To Treat Cancer

5.3.2 Growth Opportunities In The Developing Nations

5.4 Impact Analysis Of Drivers And Challenges

6. Extracellular Matrix Market - Global Analysis

6.1 Global Extracellular Matrix Market Revenue Forecasts And Analysis

6.2 Global Extracellular Matrix Market, By Geography - Forecasts And Analysis

6.3 Performance/ Positioning Of Key Players

6.3.1 Smith & Nephew

6.3.2 Dsm Biomedical

7. Extracellular Matrix Market Analysis And Forecasts To 2027 - Application

7.1 Overview

7.2 Global Extracellular Matrix Market Share By Application 2018 & 2027 (%)

7.3 Vascular Repair And Reconstruction Market

7.4 Dural Repair Market

7.5 Wound Healing Market

7.6 Cardiac Repair Market

7.7 Pericardial Repair Market

7.8 Soft Tissue Repair Market

8. Extracellular Matrix Market Analysis And Forecasts To 2027 - Raw Material

8.1 Overview

8.2 Global Extracellular Matrix Market Share By Raw Material 2018 & 2027 (%)

8.3 Bovine Market

8.4 Porcine Market

8.5 Others Market

9. Extracellular Matrix Market Revenue And Forecasts To 2027 - Geographical Analysis

10. Extracellular Matrix Market - Industry Landscape

10.1 Overview

10.2 Growth Strategies In The Extracellular Matrix Market, 2015-2019

10.3 Organic Growth Strategies

10.3.1 Overview

10.3.2 Product Launch

10.3.3 Expansion

10.3.4 Product Approval

10.4 Inorganic Growth Strategies

10.4.1 Overview

10.4.2 Agreement

10.4.3 Acquisition

10.4.4 Parnership

11. Extracellular Matrix Market-Key Company Profiles

  • Admedus
  • Coloplast Group
  • Merck KGaA
  • Smith & Nephew
  • MTF Biologics
  • Lattice Biologics Ltd.
  • COOK BIOTECH, INC.
  • Medtronic
  • Aziyo Biologics, Inc.
  • DSM Biomedical

For more information about this report visit https://www.researchandmarkets.com/r/w4kjc7

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900